Literature DB >> 7583625

Neurodevelopmental animal models of schizophrenia.

S M Lillrank1, B K Lipska, D R Weinberger.   

Abstract

One difficulty in reproducing the core neurobiological features of schizophrenia in experimental animals is that most neurobiological data about the illness are inclusive: neither the inducing conditions nor the neurobiological mechanisms have been made clear. We review the advantages and limitations of animal models of schizophrenia based on neurodevelopmental hypotheses that implicate early, probably prenatal age, as the time at which the fundamental disease process occurs. These models, although principally founded on circumstantial clinical evidence of early developmental neuropathology, seem to reproduce a surprisingly broad spectrum of prominent neurobiological aspects of the disorder, and may help explain mechanisms that underlie the pathophysiology of this illness. In particular, the model based on neonatal excitotoxic hippocampal damage has provided data indicating the neurobiological plausibility of the notion that a developmental cortical defect has a delayed effect on cortical function and dopamine regulation (i.e., the neurodevelopmental hypothesis).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7583625

Source DB:  PubMed          Journal:  Clin Neurosci        ISSN: 1065-6766


  8 in total

Review 1.  Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy.

Authors:  Amy R Brooks-Kayal; Kevin G Bath; Anne T Berg; Aristea S Galanopoulou; Gregory L Holmes; Frances E Jensen; Andres M Kanner; Terence J O'Brien; Vicky H Whittemore; Melodie R Winawer; Manisha Patel; Helen E Scharfman
Journal:  Epilepsia       Date:  2013-08       Impact factor: 5.864

Review 2.  Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine.

Authors:  M F Egan; S Chrapusta; F Karoum; B K Lipska; R J Wyatt
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  Perfusion shift from white to gray matter may account for processing speed deficits in schizophrenia.

Authors:  Susan N Wright; L Elliot Hong; Anderson M Winkler; Joshua Chiappelli; Katie Nugent; Florian Muellerklein; Xioming Du; Laura M Rowland; Danny J J Wang; Peter Kochunov
Journal:  Hum Brain Mapp       Date:  2015-06-24       Impact factor: 5.038

Review 4.  A neurobiological basis for substance abuse comorbidity in schizophrenia.

Authors:  R A Chambers; J H Krystal; D W Self
Journal:  Biol Psychiatry       Date:  2001-07-15       Impact factor: 13.382

5.  Long-Term Effects of Prenatal Hypoxia on Schizophrenia-Like Phenotype in Heterozygous Reeler Mice.

Authors:  Kristy R Howell; Anilkumar Pillai
Journal:  Mol Neurobiol       Date:  2015-06-10       Impact factor: 5.590

Review 6.  Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia.

Authors:  Stacy A Castner; Patricia S Goldman-Rakic; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-01-20       Impact factor: 4.530

Review 7.  Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage.

Authors:  Peter Kochunov; L Elliot Hong
Journal:  Schizophr Bull       Date:  2014-05-27       Impact factor: 9.306

8.  Effect on the expression of drd2 and drd3 after neonatal lesion in the lymphocytes, nucleus accumbens, hippocampus and prefrontal cortex: comparative analysis between juvenile and adult Wistar rats.

Authors:  Alma Delia Genis-Mendoza; Carlos Alfonso Tovilla-Zárate; Lilia López-Narvaez; Patricia Mendoza-Lorenzo; Patricia Ostrosky-Wegman; Humberto Nicolini; Thelma Beatriz González-Castro; Yazmin Hernández-Diaz
Journal:  Hereditas       Date:  2016-11-22       Impact factor: 3.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.